Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl for the treatment of dyspnea in patients with chronic heart failure
2008-000712-33Phase 2Completed
- Sponsor
- Medical University of Graz
- Start
- May 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fentanyl in Dyspnoea (SOB) and chronic heart failure (CHF), sponsored by Medical University of Graz. Started May 2008; status: completed.
02
Drugs
fentanyl
03
Conditions
Dyspnoea (SOB)chronic heart failure (CHF)
Beyond the preview
Go deeper on 2008-000712-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000712-33.